Zai Lab Limited ADR’s recent filing unveils that its Chief Financial Officer Chen Yajing unloaded Company’s shares for reported $0.29 million on Jun 02 ’25. In the deal valued at $30.00 per share,9,618 shares were sold. As a result of this transaction, Chen Yajing now holds 17,429 shares worth roughly $0.66 million.
Then, Chen Yajing bought 9,618 shares, generating $288,540 in total proceeds.
Before that, Du Ying sold 50,000 shares. Zai Lab Limited ADR shares valued at $1,428,650 were divested by the Chairperson & CEO at a price of $28.57 per share. As a result of the transaction, Du Ying now holds 479,851 shares, worth roughly $18.29 million.
Scotiabank initiated its Zai Lab Limited ADR [ZLAB] rating to a Sector outperform in a research note published on March 07, 2025; the price target was $55. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Neutral”. Morgan Stanley began covering ZLAB with “an Overweight” recommendation on December 14, 2023. Cantor Fitzgerald started covering the stock on August 10, 2023. It rated ZLAB as “an Overweight”.
Price Performance Review of ZLAB
On Friday, Zai Lab Limited ADR [NASDAQ:ZLAB] saw its stock jump 4.30% to $38.11. Over the last five days, the stock has gained 26.44%. Zai Lab Limited ADR shares have risen nearly 45.51% since the year began. Nevertheless, the stocks have risen 97.56% over the past one year. While a 52-week high of $39.77 was reached on 03/28/25, a 52-week low of $16.01 was recorded on 01/15/25. SMA at 50 days reached $31.58, while 200 days put it at $28.39.
Levels Of Support And Resistance For ZLAB Stock
The 24-hour chart illustrates a support level at 37.38, which if violated will result in even more drops to 36.66. On the upside, there is a resistance level at 38.64. A further resistance level may holdings at 39.18. The Relative Strength Index (RSI) on the 14-day chart is 70.44, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.21, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.70%. Stochastics %K at 95.68% indicates the stock is a selling.
The most recent change occurred on January 21, 2022 when Macquarie began covering the stock and recommended ‘”an Outperform”‘ rating along with a $64 price target.
